| |
 |
|
Class Information
Number: 514/330
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., o,s,se or te) or nitrogen as the only ring hetero atoms doai > Hetero ring is six-membered consisting of one nitrogen and five carbon atoms > Piperidines > Additional ring containing > C=x bonded directly to the piperidine ring (x is chalcogen)
Description: Subject matter wherein a C=O, C=S, C=Se or C=Te group is bonded directly to the piperidine ring.
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7022687 |
Combination of loteprednol and antihistamines |
Apr. 4, 2006 |
| 7019003 |
Peptide deformylase inhibitors |
Mar. 28, 2006 |
| 7015235 |
Acylated piperidine derivatives as melanocortin-4 receptor agonists |
Mar. 21, 2006 |
| 7012084 |
Acylated piperidine derivatives as melanocortin-4 receptor agonists |
Mar. 14, 2006 |
| 7001915 |
Ultrashort-acting opioids for transdermal applications |
Feb. 21, 2006 |
| 6977264 |
Substituted piperidines and methods of use |
Dec. 20, 2005 |
| 6977263 |
Chemical compounds |
Dec. 20, 2005 |
| 6969713 |
Piperidine and piperazine acetamide derivatives |
Nov. 29, 2005 |
| 6958331 |
Bradykinin receptor antagonists |
Oct. 25, 2005 |
| 6958352 |
Compounds for inhibiting insulin secretion and methods related thereto |
Oct. 25, 2005 |
| 6949257 |
Pharmaceutical compositions |
Sep. 27, 2005 |
| 6949545 |
Heterocyclic side chain containing, n-substituted metalloprotease inhibitors |
Sep. 27, 2005 |
| 6946478 |
Compounds |
Sep. 20, 2005 |
| 6943177 |
Cis-2,6-disubstituted piperidines for the treatment of psychostimulant abuse and withdrawal, eating disorders, and central nervous system diseases and pathologies |
Sep. 13, 2005 |
| 6916821 |
Methods of treating disorders with Group I mGluR antagonists |
Jul. 12, 2005 |
| 6916800 |
Combination therapy including a matrix metalloproteinase inhibitor and an antineoplastic agent |
Jul. 12, 2005 |
| 6900203 |
Optically active fluorinated vasoconstrictors, methods for making them, and anesthetic formulations comprising them |
May. 31, 2005 |
| 6894059 |
Compounds and methods for treatment of asthma, allergy and inflammatory disorders |
May. 17, 2005 |
| 6890931 |
Methods of treating disorders with group I mGluR antagonists |
May. 10, 2005 |
| 6881409 |
Compositions and methods for promoting nerve regeneration |
Apr. 19, 2005 |
| 6881756 |
Method for treating skin disorders |
Apr. 19, 2005 |
| 6878712 |
Amides as inhibitors for pyruvate dehydrogenase |
Apr. 12, 2005 |
| 6878706 |
Cyanamides useful as reversible inhibitors of cysteine proteases |
Apr. 12, 2005 |
| 6872735 |
LFA-1 antagonist compounds |
Mar. 29, 2005 |
| 6867221 |
Cyclic amine compounds and pharmaceutical composition containing the same |
Mar. 15, 2005 |
| 6867184 |
Methods of treating diabetic cardiomyopathy using glycogen phosphorylase inhibitors |
Mar. 15, 2005 |
| 6864249 |
Piperidine and azetidine thrombin inhibitors |
Mar. 8, 2005 |
| 6858598 |
Method of using a matrix metalloproteinase inhibitor and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia |
Feb. 22, 2005 |
| 6858626 |
Cyclic hydroxamic acid as metalloproteinase inhibitors |
Feb. 22, 2005 |
| 6858628 |
Substituted cyclic amine metalloprotease inhibitors |
Feb. 22, 2005 |
| 6855706 |
Phenylalanine derivatives |
Feb. 15, 2005 |
| 6852738 |
Acyl sulfamides for treatment of obesity, diabetes and lipid disorders |
Feb. 8, 2005 |
| 6849622 |
Aliphatic nitrogenous five-membered ring compounds |
Feb. 1, 2005 |
| 6835388 |
Medicament against dysmenorrhoea and premenstrual syndrome |
Dec. 28, 2004 |
| 6818659 |
(2S)-2-amino-4-(2-amino-(3,4,5,6-tetrahydropyrimidin-4-yl) butanoyl and its use in cyclic and acyclic peptides |
Nov. 16, 2004 |
| 6806291 |
Analgesic compounds, their synthesis and pharmaceutical compositions containing them |
Oct. 19, 2004 |
| 6800619 |
Caspase inhibitors and uses thereof |
Oct. 5, 2004 |
| 6784193 |
Mutilin derivatives and their use as antibacterials |
Aug. 31, 2004 |
| 6784186 |
Therapeutic compounds |
Aug. 31, 2004 |
| 6784182 |
Serine protease inhibitors |
Aug. 31, 2004 |
| 6777428 |
5-HT1f agonist |
Aug. 17, 2004 |
| 6770656 |
Amine derivatives for the treatment of apoptosis |
Aug. 3, 2004 |
| 6770659 |
Benzoyl piperidine compounds |
Aug. 3, 2004 |
| 6767915 |
Substituted piperidines as melanocortin receptor agonists |
Jul. 27, 2004 |
| 6753337 |
Alkynyl containing hydroxamic acid compounds as matrix metalloproteinase/tace inhibitors |
Jun. 22, 2004 |
| 6750228 |
Aromatic sulfone hydroxamic acid metalloprotease inhibitor |
Jun. 15, 2004 |
| 6743790 |
Factor VIIa inhibitory (thio)urea derivatives, their preparation and their use |
Jun. 1, 2004 |
| 6737420 |
Compounds to treat Alzheimer's disease |
May. 18, 2004 |
| 6723753 |
Substituted n-benzyl-n-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
Apr. 20, 2004 |
| RE38506 |
Potent inducers of terminal differentiation and methods of use thereof |
Apr. 20, 2004 |
|
|
|
